Tuesday, April 13, 2021

Pentagon develops microchip that detects COVID under your skin


By Hannah Sparks

April 12, 2021 | 1:30pm

Medical researchers at the Pentagon have created a microchip that will detect COVID-19 when inserted under the skin.

Relax, conspiracy theorists — they’re not being disseminated via vaccines.

The revolutionary technology was developed by the Defense Advanced Research Projects Agency, which operates under the Pentagon umbrella, according to Sunday night’s broadcast of “60 Minutes.” The top-secret unit was launched during the Cold War to study emerging technologies for military use — among them, innovations to defend soldiers from biological weapons.

Retired Army Col. Dr. Matt Hepburn, an infectious disease physician, revealed that the microchip, which is not in widespread use outside the Defense Department, could detect COVID-19 in an individual well before a patient zero spawns an outbreak.


In a “60 Minutes” interview, Pentagon researchers claim they’ve created a microchip that will detect COVID-19 when inserted under the skin, and other disease-fighting technologies.CBS

“We challenge the research community to come up with solutions that may sound like science fiction,” said Hepburn, whose role at DARPA, he added, is to “take pandemics off the table.”

Hepburn compared their diagnostic microchip to a car’s “check engine” alert.

Despite conspiracy theories that claim Microsoft’s Bill Gates is using vaccines as a vehicle to insert a microscopic global positioning system into our bodies, “60 Minutes” clarified that DARPA’s chip would not “track your every move.” Nor is it being administered via shots, as some would-be Twitter sleuths have pondered.

Defense Department researcher Dr. Matt Hepburn compared the COVID-19 detection microchip to a car’s “check engine” light.CBS

“It’s a sensor,” Hepburn told CBS correspondent Bill Whitaker. “That tiny green thing in there, you put it underneath your skin and what that tells you is that there are chemical reactions going on inside the body and that signal means you are going to have symptoms tomorrow.”

The microchip, embedded in a tissue-like gel, is designed to continuously test the chip recipient’s blood for presence of the virus. Once COVID-19 is detected, the chip alerts the patient to conduct a rapid blood test, which can be self-administered, to confirm the positive result.


This dialysis machine attachment can filter the coronavirus out of patients’ blood.CBS

“We can have that information in three to five minutes,” Hepburn said. “As you truncate that time, as you diagnose and treat, what you do is you stop the infection in its tracks.”

The segment also revealed technology that would allow a standard dialysis machine to remove COVID-19 from the blood using a customized filter. Blood is passed through the machine, where it’s detoxed, then pumped back into the body in a continuous stream until the body is rid of the virus.


The USS Theodore Roosevelt was hit with a coronavirus outbreak affecting 1,271 crew members last year.Anadolu Agency via Getty Images

A military spouse dubbed “Patient 16” survived a severe bout of the illness, including organ failure and septic shock, thanks to the novel dialysis machine. Treatment lasted four days, after which Patient 16 had made a full recovery.

DARPA scientists say that their research is critically important to preventing outbreaks in crowded military quarters, such as the one that occurred on the USS Theodore Roosevelt in March and April 2020, which saw 1,271 crewmates test positive for the coronavirus.


DARPA scientists say that their research is critically important to preventing outbreaks in crowded military quarters, such as naval ships.Gamma-Rapho via Getty Images

Pentagon researchers continue to study COVID-19, and much of their research has been critical in stopping the pandemic, including new methods of detecting and developing antibodies in about 10 weeks — a fraction of the six to 24 months previously required.

They eventually hope to close the gap between new disease detection and vaccine development.

Eventually, said DARPA scientist Dr. James Crowe, “We would start from a blood sample from a survivor … and be giving you an injection of the cure within the 60 days.”

“For us, at DARPA, if the experts are laughing at you and saying it’s impossible, you’re in the right space,” said Hepburn.




No comments: